All questionsDosing and administration: Enhertu (fam-trastuzumab deruxtecan-nxki), all indications7 questions · 4 sourcesPremedicationDoes Enhertu need anti-nausea premedication?“INITIATE PROPHYLAXIS: ENHERTU is highly emetogenic, which can cause delayed nausea and/or vomiting. Administer prophylactic antiemetic medications per local institutional guidelines for prevention of chemotherapy-induced nausea and vomiting1” (opens the source at this quote in a new tab)CopyFlag“Fam-trastuzumab deruxtecan-nxki (ENHERTU®) is classified as highly emetogenic, which includes delayed nausea and/or vomiting1,2” (opens the source at this quote in a new tab)CopyFlagDosingWhat are the Enhertu dose reduction levels?“Dose reduction schedule Breast Cancer, NSCLC, and IHC 3+ Solid Tumors Gastric Cancer Recommended starting dose 5.4 mg/kg 6.4 mg/kg First dose reduction 4.4 mg/kg 5.4 mg/kg Second dose reduction 3.2 mg/kg 4.4 mg/kg Requirement for further dose reduction Discontinue treatment” (opens the source at this quote in a new tab)CopyFlag“Do not re-escalate the ENHERTU dose after a dose reduction is made” (opens the source at this quote in a new tab)CopyFlagNote: The first column (5.4 mg/kg starting dose) applies to breast cancer, including HER2-low and HER2-ultralow metastatic breast cancer; the second column applies to gastric cancer.What if an Enhertu dose is missed or delayed?“If a planned dose is delayed or missed, administer as soon as possible; do not wait until the next planned cycle. Adjust the schedule of administration to maintain a 3-week interval between doses. Administer the infusion at the dose and rate the patient tolerated in the most recent infusion” (opens the source at this quote in a new tab)CopyFlagAdministrationHow long does an Enhertu infusion take?“First infusion: Administer infusion over 90 minutes Subsequent infusions: Administer over 30 minutes if prior infusions were well tolerated” (opens the source at this quote in a new tab)CopyFlag“Do NOT administer as an intravenous push or bolus” (opens the source at this quote in a new tab)CopyFlag“Administer ENHERTU with a 0.20 or 0.22 micron in-line polyethersulfone (PES) or polysulfone (PS) filter” (opens the source at this quote in a new tab)CopyFlagBefore treatmentWhat should be checked before starting Enhertu and during treatment?“Before administering ENHERTU • Monitor complete blood counts prior to initiation and prior to each dose, and as clinically indicated • Assess LVEF prior to initiation and at regular intervals during treatment as clinically indicated • Verify pregnancy status of females” (opens the source at this quote in a new tab)CopyFlagPreparationHow is Enhertu reconstituted and diluted?“Reconstitution1 Reconstitute immediately before dilution More than one vial may be needed for a full dose. Calculate the dose (mg), the total volume of reconstituted ENHERTU solution required, and the number of vial(s) of ENHERTU needed Reconstitute each 100 mg vial by using a sterile syringe to slowly inject 5 mL of Sterile Water for Injection, USP into each vial to obtain a final concentration of 20 mg/mL Swirl the vial gently until completely dissolved. Do not shake” (opens the source at this quote in a new tab)CopyFlag“Dilution1 Withdraw the calculated amount from the vial(s) using a sterile syringe. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. The solution should be clear and colorless to light yellow. Do not use if visible particles are observed or if the solution is cloudy or discolored Dilute the calculated volume of reconstituted ENHERTU in an intravenous infusion bag containing 100 mL of 5% Dextrose Injection, USP. DO NOT use Sodium Chloride Injection, USP. ENHERTU is compatible with an infusion bag made of polyvinylchloride or polyolefin (copolymer of ethylene and polypropylene) Gently invert the infusion bag to thoroughly mix the solution. Do not shake Cover the infusion bag to protect from light Discard any unused portion left in the vials” (opens the source at this quote in a new tab)CopyFlagCan Enhertu be substituted for trastuzumab or ado-trastuzumab emtansine?“Do not substitute ENHERTU for or with trastuzumab or ado-trastuzumab emtansine” (opens the source at this quote in a new tab)CopyFlag“In order to prevent medication errors, check the vial labels to ensure that the drug being prepared and administered is ENHERTU and not trastuzumab or ado-trastuzumab emtansine.1” (opens the source at this quote in a new tab)CopyFlag